Live Breaking News & Updates on Chronic Congestive Heart Failure

Stay updated with breaking news from Chronic congestive heart failure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA OKs Vericiguat for Unique HF Population

email article
FDA approved vericiguat (Verquvo) on Wednesday to lower cardiovascular events in patients with heart failure with reduced ejection fraction (HFrEF) who had recently been hospitalized or had received IV diuretic therapy, Merck announced.
The soluble guanylate cyclase (sGC) stimulator was cleared as a therapy that reduces the risk of cardiovascular death and heart failure hospitalization in these patients. This makes it the first chronic heart failure treatment approved specifically for the recently decompensated population.
Regulatory approval was based on the VICTORIA trial, first presented at the 2020 virtual American College of Cardiology annual meeting, which had 5,050 recently decompensated HFrEF patients randomized to vericiguat (up to 10 mg once daily) or placebo. ....

Nicole Lou , Paul Armstrong , University Of Alberta , American College Of Cardiology , American College , Medpage Today , Left Heart Failure , Congestive Heart Failure , Heart Failure , Chronic Congestive Heart Failure , Psychoactive Substance Dependence , நிக்கோல் லூ , பால் ஆம்ஸ்ட்ராங் , பல்கலைக்கழகம் ஆஃப் ஆல்பர்ட்டா , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , அமெரிக்கன் கல்லூரி , இடது இதயம் தோல்வி , நெரிசல் இதயம் தோல்வி , இதயம் தோல்வி , நாள்பட்ட நெரிசல் இதயம் தோல்வி ,

Telehealth Waivers Extended; Virtual Visit Triage; Post-MI Remote Care

Claims Lines Steady as Waivers Extended
The Department of Health and Human Services (HHS) extended the COVID-19 public health emergency including key waivers for telehealth until April 2021,
Under the emergency, HHS has allowed more types of providers to bill Medicare for telehealth services and has granted waivers for audio-only telemedicine to be reimbursed.
The extension comes as new FAIR Health data show that telehealth claim lines the individual services or procedures listed on an insurance claim continued to be relatively steady through October, though wildly outpacing 2019 levels.
Telehealth accounted for 5.61% of medical claims lines in October 2020, a giant leap from 0.18% in October 2019, the nonprofit s Monthly Telehealth Regional Tracker showed. ....

National University Of Singapore , Singapore General , Judy George , Mark Chan , University Of California Los Angeles , Department Of Health , Human Services , Telehealth Roundup , Lines Steady , Monthly Telehealth Regional Tracker , California Los Angeles , National University , Medpage Today , Heart Disease , Chronic Congestive Heart Failure , Developmental Academic Disorder , Heart Failure , தேசிய பல்கலைக்கழகம் ஆஃப் சிங்கப்பூர் , சிங்கப்பூர் ஜநரல் , ஜூடி ஜார்ஜ் , குறி சான் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா லாஸ் ஏஞ்சல்ஸ் , துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , டெலிஹெல்த் ரவுண்டப் , கோடுகள் நிலையான ,

ACC Updates Heart Failure Guidance, Highlights New Drugs

email article
Streamlined interim heart failure guidance, including newer therapies and acknowledging the changes in care wrought by the COVID-19 pandemic, was released by the American College of Cardiology (ACC).
Angiotensin receptor-neprilysin inhibitors (ARNIs) and SGLT2 inhibitors were added to the treatment algorithms for new-onset and chronic heart failure in this update to the ACC s 2017 expert consensus decision pathway (ECDP) for treatment of heart failure with reduced ejection fraction (HFrEF).
The document was meant to serve as interim guidance while the ACC drafts more comprehensive heart failure guidelines, according to the writing group chaired by Thomas Maddox, MD, MSc, of Washington University School of Medicine in St. Louis. ....

Nicole Lou , Thomas Maddox , American College Of Cardiology , Journal Of The American College Cardiology , Washington University School Of Medicine , American College , Washington University School , Medpage Today , Congenital Malformation , Disorder Of Brain , Chronic Congestive Heart Failure , Mitral Valve Regurgitation , Heart Failure , நிக்கோல் லூ , தாமஸ் ம்யாடக்ஸ் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , அமெரிக்கன் கல்லூரி , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , பிறவி சிதைவு , கோளாறு ஆஃப் மூளை , நாள்பட்ட நெரிசல் இதயம் தோல்வி , இதயம் தோல்வி ,